|
| |
Kendle (Nasdaq: KNDL)Kendle (Nasdaq: KNDL) is among the world’s leading global clinical research organizations. We deliver innovative and robust clinical development solutions – from “first-in-human” studies through market launch and surveillance – to help the world’s biopharmaceutical companies maximize product life cycles and grow market share.Our focus is on large and multinational clinical development programs in important areas of research, such as oncology, CNS, analgesia/pain, inflammation, gastroenterology and cardiovascular. Through our upfront strategic planning and feasibility assessments, we can help you access, recruit and retain patients to meet your study inclusion criteria and program timelines.
| Contact Details: |
| 1200 Carew Tower441 Vine Street |
| Cincinnati |
| Ohio |
| 45202 |
| United States of America |
| Tel: | 1 513 381 5550 |
| Fax: | 1 513 381 5870 |
| Email: | |
| WWW: | www.kendle.com/
|
|
Loading...
|
Press Releases on Kendle (Nasdaq: KNDL):
|
 |
| Kendle Announces Third Quarter 2009 Results |
4th November, 2009 |
Kendle International Inc. |
CINCINNATI, Nov. 4 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today reported solid net income of $8.8 million or $0.59 per diluted
|
| Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting |
2nd November, 2009 |
Kendle International Inc. |
CINCINNATI, Nov. 2 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the appointment of J. Michael Sprafka, MPH, PhD, as
|
| Kendle's TrialEAS(TM) Electronic Adjudication System Named 'Best Technological Development in Clinical Trials - Software Solution' in GCPj Clinical Research Excellence Awards |
21st October, 2009 |
Kendle International Inc. |
CINCINNATI, Oct. 21 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced its proprietary electronic adjudication system
|
| Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast |
13th October, 2009 |
Kendle International Inc. |
CINCINNATI, Oct. 13 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) announced today that it will release its third quarter 2009 financial results after the market closes on Wednesday, Nov. 4, 2009.
|
| Kendle Appoints John Needham Executive Director and Global Head, Patient Enrollment Strategy |
5th October, 2009 |
Kendle International Inc. |
CINCINNATI, Oct. 5 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the appointment of John Needham as Executive Director
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 299 times since April 2007, the link to the organisation's website has been followed 80 times Recent Search Terms used to find this page: NASDAQ KNDL | NASDAQ KNDL | NASDAQ KNDL | . Search for more companies in Cincinnati Search for more companies in Ohio This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Kendle (Nasdaq: KNDL) |
